SavedAdd your journal

Journals / Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi / 2020 / Cilt: 13 - Sayı: 3

Inhibitory effects of the chalcones towards carbonic anhydrase I, II and acetylcholinesterase enzymes

Şalkonların karbonik anhidraz I, II ve asetilkolinesteraz enzimlerine karşı inhibisyon etkileri

Mehtap TUĞRAK
Cem YAMALI
Halise İnci GÜL
Yeliz DEMİR
Pages
1138–1146
Publication Date
2020-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The bioassay results showed that the compounds can be considered as the main frame to design novel chalcone-based enzyme inhibitors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chalcones are known as versatile, innovative and bioactive chemical scaffolds in drug development studies.
📊
Key Findings & Data:In this study, a series of poly-methoxylated chalcones (1-8) were synthesized by Claisen-Schmidt condensation under the basic condition and their carbonic anhydrase (CA) I/II and acetylcholinesterase (AChE) inhibitory effects were firstly evaluated in this study.
💡
Conclusion & Impact:The bioassay results showed that the compounds can be considered as the main frame to design novel chalcone-based enzyme inhibitors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:chalcone · carbonic anhydrase · acetylcholine esterase

Abstract

Chalcones are known as versatile, innovative and bioactive chemical scaffolds in drug development studies. In this study, a series of poly-methoxylated chalcones (1-8) were synthesized by Claisen-Schmidt condensation under the basic condition and their carbonic anhydrase (CA) I/II and acetylcholinesterase (AChE) inhibitory effects were firstly evaluated in this study. CA isoenzymes I and II were inhibited in nanomolar concentration with Ki values of 8.75±0.64 - 37.64±2.38 nM (hCA I) and 11.47±3.31- 45.97±4.67 nM (hCA II). The compounds inhibited the AChE enzyme in the range of 34.14±20.79 - 53.65±13.25 nM. The compounds 1, 3 and 5 were the best inhibitors against hCA I, hCA II, and AChE, respectively. The bioassay results showed that the compounds can be considered as the main frame to design novel chalcone-based enzyme inhibitors.

Özet

Şalkonlar ilaç geliştirme çalışmalarında kullanışlı, yenilikçi ve biyoaktif kimyasal yapı iskeletleri olarak bilinirler. Bu çalışmada, bir dizi poli-metoksillenmiş şalkonlar (1-8) bazik koşul altında Claisen-Schmidt kondansasyonu ile sentezlendi ve karbonik anhidraz (CA) I / II ve asetilkolinesteraz (AChE) inhibitör etkileri ilk olarak bu çalışmada değerlendirildi. CA izoenzimleri olan I ve II, 8.75 ± 0.64 - 37.64 ± 2.38 nM (hCA I) ve 11.47 ± 3.31- 45.97 ± 4.67 nM (hCA II) Ki değerleri ile nanomolar konsantrasyonda inhibe edildi. Bileşikler, AChE enzimini 34.14 ± 20.79 - 53.65 ± 13.25 nM aralığında inhibe etti. Bileşik 1, 3 ve 5, sırasıyla hCA I, hCA II ve AChE'ye karşı en güçlü inhibitörlerdir. Biyolojik aktivite sonuçları, bileşiklerin yeni şalkon bazlı enzim inhibitörleri tasarlamak için ana yapı olarak kabul edilebildiğini gösterdi. Chalcones are known as versatile, innovative and bioactive chemical scaffolds in drug development studies. In this study, a series of poly-methoxylated chalcones (1-8) were synthesized by Claisen-Schmidt condensation under the basic condition and their carbonic anhydrase (CA) I/II and acetylcholinesterase (AChE) inhibitory effects were firstly evaluated in this study. CA isoenzymes I and II were inhibited in nanomolar concentration with Ki values of 8.75±0.64 - 37.64±2.38 nM (hCA I) and 11.47±3.31- 45.97±4.67 nM (hCA II). The compounds inhibited the AChE enzyme in the range of 34.14±20.79 - 53.65±13.25 nM. The compounds 1, 3 and 5 were the best inhibitors against hCA I, hCA II, and AChE, respectively. The bioassay results showed that the compounds can be considered as the main frame to design novel chalcone-based enzyme inhibitors.

🔖

Cite This Article

TUĞRAK, M., YAMALI, C., GÜL, H. İ., DEMİR, Y. (2020). Inhibitory effects of the chalcones towards carbonic anhydrase I, II and acetylcholinesterase enzymes. Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Cilt: 13 - Sayı: 3, 1138–1146. https://ajindex.com/articles/233883

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Alpan, A.S., Sarıkaya, G., Coban, G., Parlar, S., Armagan, G., Alptuzun, V. 2017. ‘’Mannich-Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study’’. Arch Pharm (Weinheim), 350(7), e1600351. Burmaoglu, S., Yilmaz, A.O., Polat, M.F., Kaya, R., Gulcin, I., Algul, O. 2019. ‘’Synthesis and Biological Evaluation of Novel Tris-Chalcones as Potent Carbonic Anhydrase, Acetylcholinesterase, Butyrylcholinesterase and Alpha-Glycosidase İnhibitors’’. Bioorg Chem, 85, 191-197.
  2. Ellman, G.L., Courtney, K.D., Andres, V., Jr., Feather-Stone, R.M. 1961. ‘’A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity’’. Biochem Pharmacol, 7, 88-95.
  3. Gomes, M.N., Muratov, E.N., Pereira, M., Peixoto, J.C., Rosseto, L.P., Cravo, P.V.L., Andrade, C.H., Neves, B.J. 2017. ‘’Chalcone Derivatives: Promising Starting Points for Drug Design’’. Molecules, 22(8), E1210 Gul, H.I., Yamali, C., Bulbuller, M., Kirmizibayrak, P.B., Gul, M., Angeli, A., Bua, S., Supuran, C.T. 2018a. ‘’Anticancer Effects of New Dibenzenesulfonamides by Inducing Apoptosis and Autophagy Pathways and Their Carbonic Anhydrase İnhibitory Effects on hCA I, hCA II, hCA IX, hCA XII Isoenzymes’’. Bioorg Chem, 78, 290-297.
  4. Gul, H.I., Yamali, C., Sakagami, H., Angeli, A., Leitans, J., Kazaks, A., Tars, K., Ozgun, D.O., Supuran, C.T. 2018b. ‘’New Anticancer Drug Candidates Sulfonamides as Selective hCA IX or hCA XII Inhibitors’’. Bioorg Chem, 77, 411-419.
  5. Li, Y., Qiang, X., Luo, L., Yang, X., Xiao, G., Zheng, Y., Cao, Z., Sang, Z., Su, F., Deng, Y. 2017. ‘’Multitarget Drug Design Strategy Against Alzheimer's Disease: Homoisoflavonoid Mannich Base Derivatives Serve As Acetylcholinesterase and Monoamine Oxidase B Dual Inhibitors with Multifunctional Properties’’. Bioorg Med Chem, 25(2), 714-726.
  6. Mahar, J., Saeed, A., Belfield, K.D., Ali Larik, F., Ali Channar, P., Ali Kazi, M., Abbas, Q., Hassan, M., Raza, H., Seo, S.Y. 2019. ‘’1-(2-Hydroxy-5-((trimethylsilyl)ethynyl)phenyl)ethanone Based Alpha, Beta-Unsaturated Derivatives An Alternate To Non-Sulfonamide Carbonic Anhydrase II Inhibitors, Synthesis Via Sonogashira Coupling, Binding Analysis, Lipinsk's Rule Validation’’. Bioorg Chem, 84, 170-6.
  7. Ozgun, D.O., Gul, H.I., Yamali, C., Sakagami, H., Gulcin, I., Sukuroglu, M., Supuran, C.T. 2019. ‘’Synthesis and Bioactivities of Pyrazoline Benzensulfonamides as Carbonic Anhydrase and Acetylcholinesterase Inhibitors With Low Cytotoxicity